Clinical audit examining the impact of benzalkonium chloride-free anti-glaucoma medications on patients with symptoms of ocular surface disease

Ivan Goldberg*, Stuart L. Graham, Jonathan G. Crowston, Guy d'Mellow, Australian and New Zealand Glaucoma Interest Group

*Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    27 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Clinical audit examining the impact of benzalkonium chloride-free anti-glaucoma medications on patients with symptoms of ocular surface disease'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science